The role of G protein-coupled signaling in neurocognitive and psychosocialabnormalities
G 蛋白偶联信号在神经认知和心理社会异常中的作用
基本信息
- 批准号:9234576
- 负责人:
- 金额:$ 21.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-10-28 至 2020-02-29
- 项目状态:已结题
- 来源:
- 关键词:AdultAllelesBehaviorBehavioralBrainChildChildhoodClinicCognitionCognitiveCognitive deficitsCollaborationsCoupledDNADataDevelopmentDiseaseDisease ManagementEndocrineEndocrinologistEtiologyFrameshift MutationFunctional disorderG-substrateGNAS geneGTP-Binding ProteinsGeneral PopulationGenesGenotypeGnas proteinGoalsHereditary DiseaseHome environmentHormonalHormonesHumanHypothalamic structureImpairmentInheritedInstitutesInvestigationLeadLinkLymphocyteMetabolicMissense MutationMutationMutation AnalysisNamesNeurocognitiveNeurocognitive DeficitNeurodevelopmental DisorderNonsense MutationObesityPatientsPhenotypePhysiologic OssificationPhysiologicalPituitary GlandPlayPopulationProteinsPseudohypoparathyroidismPseudopseudohypoparathyroidismPsychosocial Assessment and CareQuality of lifeResistanceRoleSecondary toSeveritiesSignal TransductionSomatotropin-Releasing HormoneTissuesTranscriptVariantbaseclinical carecohortgenotypic sexgrowth hormone deficiencyimprintmouse modelpaternal imprintpsychosocialpublic health relevancesexual dimorphismsocialsubcutaneous
项目摘要
DESCRIPTION (provided by applicant): Albright hereditary osteodystrophy (AHO) is a rare genetic disorder caused by heterozygous inactivating mutations in GNAS, the gene encoding the α chain of Gs (Gαs), and is associated with short stature, brachydactyly, subcutaneous ossifications, and cognitive deficits. AHO patients with GNAS mutations on maternally inherited alleles manifest resistance to multiple hormones (e.g. PTH, TSH, LH, FSH, GHRH) as well as obesity, a variant termed pseudohypoparathyroidism type 1a (PHP1a), due to paternal imprinting of Gαs transcripts in specific tissues. AHO patients with GNAS mutations on paternally inherited alleles have the same phenotype but without hormonal resistance and marked obesity, a variant termed pseudopseudo- hypoparathyroidism (PPHP). Although both PHP1a and PPHP have been described as displaying cognitive deficits, we have found that patients with PHP1a lead compromised lives academically and socially, whereas those with PPHP do not. Based on preliminary data in a large cohort of patients with AHO as well as a mouse model, we hypothesize that the neurocognitive and psychosocial impairments observed in AHO are specific to PHP1a and may be secondary to imprinting in the brain. The aims of this study are four-fold and will be examined by forming a new collaboration between Dr. Germain-Lee, who has expertise in AHO (and established the Albright Clinic at Kennedy Krieger Institute), and Drs. Mahone and Ramos (married name, Scarborough), who have expertise in neurocognitive and psychosocial assessments. First, we plan to examine children and adults with PHP1a systematically for neurocognitive and psychosocial dysfunction. Second, we will compare PHP1a patients with PPHP patients in order to define the differences in these populations which have previously been assumed as similar in terms of these parameters. Third, because the patients being examined in this study have had or will have DNA and transformed lymphocytes banked and mutation analyses performed, we can begin to correlate the neurocognitive and psychosocial phenotypes with genotypes as well as with levels of Gαs protein/message levels and Gαs activity. Finally, we will correlate these phenotypes/genotypes with hormonal and metabolic parameters, providing a unique opportunity to link cognition and behavior to endocrine function as well as examine potential sexual dimorphisms. The overall goals of this study are to define the neurocognitive and psychosocial phenotypes in PHP1a versus PPHP and to establish the role of imprinting and G protein-coupled signaling, as well as genotype, sex, and endocrine function, in the etiology of the differences that are found. This study may reveal disorders unique to PHP1a and therefore target management more specifically, leading to improvements in the treatment and quality of life of these patients. In addition, the specific cognitive and behavioral phenotypes found in PHP1a are likely to be significant problems in the general population, and their mechanisms may be further elucidated through investigations of the role of imprinting of GNAS and G protein-coupled signaling.
描述(由申请人提供):奥尔布赖特遗传性骨营养不良 (AHO) 是一种罕见的遗传性疾病,由 GNAS 杂合失活突变引起,GNAS 是编码 Gs α 链 (Gαs) 的基因,与身材矮小、短指、皮下骨化、母系遗传等位基因 GNAS 突变的 AHO 患者表现出对多种激素(例如 PTH、具有父系遗传等位基因 GNAS 突变的 AHO 患者具有相同的表型,但没有激素抵抗和明显的肥胖,这是一种称为假性甲状旁腺功能减退症 (PPHP) 的变异,尽管 PHP1a 和 PPHP 都被描述为表现出认知缺陷,我们发现 PHP1a 患者的学业和社交生活受到损害,而 PPHP 患者则不然。根据大量 AHO 患者和小鼠模型的初步数据,我们发现,神经认知和社交能力受到影响。在 AHO 中观察到的社会心理障碍是 PHP1a 所特有的,并且可能继发于大脑中的印记。这项研究的目的有四个,并将通过与 Germain-Lee 博士之间的新合作来进行研究。首先,我们计划对患有 PHP1a 的儿童和成人进行系统性检查。其次,我们将比较 PHP1a 患者与 PPHP 患者,以确定这些人群的差异,这些差异之前被认为在这些参数方面是相似的。在这项研究中被检查的人已经或将要储存 DNA 和转化淋巴细胞并进行突变分析,我们可以开始将神经认知和心理社会表型与基因型以及 Gαs 蛋白/信息水平和 Gαs 活性联系起来。将这些表型/基因型与激素和代谢参数相关联,提供独特的机会将认知和行为与内分泌功能联系起来,并检查潜在的性别二态性。这项研究的总体目标是定义。 PHP1a 与 PPHP 的神经认知和心理社会表型,并确定印记和 G 蛋白偶联信号传导以及基因型、性别和内分泌功能在所发现差异的病因学中的作用。这项研究可能揭示独特的疾病。 PHP1a,因此更具体地进行目标管理,从而改善这些患者的治疗和生活质量。此外,在 PHP1a 中发现的特定认知和行为表型可能是该患者的重大问题。通过研究 GNAS 印记和 G 蛋白偶联信号传导的作用,可以进一步阐明其机制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.
Gsα 失活的亲代起源对奥尔布赖特遗传性骨营养不良小鼠模型的骨重塑有不同的影响。
- DOI:
- 发表时间:2022-01
- 期刊:
- 影响因子:3.8
- 作者:McMullan, Patrick;Maye, Peter;Yang, Qingfen;Rowe, David W;Germain
- 通讯作者:Germain
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EMILY L GERMAIN-LEE其他文献
EMILY L GERMAIN-LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EMILY L GERMAIN-LEE', 18)}}的其他基金
Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteins
通过转化生长因子相关配体及其结合蛋白对骨量进行细胞外调节
- 批准号:
10537833 - 财政年份:2022
- 资助金额:
$ 21.14万 - 项目类别:
Elucidating extragonadal functions of follicle stimulating hormone using genetic approaches in mice
利用小鼠遗传方法阐明促卵泡激素的性腺外功能
- 批准号:
10685473 - 财政年份:2022
- 资助金额:
$ 21.14万 - 项目类别:
Elucidating extragonadal functions of follicle stimulating hormone using genetic approaches in mice
利用小鼠遗传方法阐明促卵泡激素的性腺外功能
- 批准号:
10685473 - 财政年份:2022
- 资助金额:
$ 21.14万 - 项目类别:
Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteins
通过转化生长因子相关配体及其结合蛋白对骨量进行细胞外调节
- 批准号:
10669763 - 财政年份:2022
- 资助金额:
$ 21.14万 - 项目类别:
Elucidating extragonadal functions of follicle stimulating hormone using genetic approaches in mice
利用小鼠遗传方法阐明促卵泡激素的性腺外功能
- 批准号:
10534492 - 财政年份:2022
- 资助金额:
$ 21.14万 - 项目类别:
The role of G protein-coupled signaling in neurocognitive and psychosocialabnormalities
G 蛋白偶联信号在神经认知和心理社会异常中的作用
- 批准号:
9331967 - 财政年份:2016
- 资助金额:
$ 21.14万 - 项目类别:
The role of G protein-coupled signaling in neurocognitive and psychosocial abnormalities
G 蛋白偶联信号在神经认知和心理社会异常中的作用
- 批准号:
9035448 - 财政年份:2016
- 资助金额:
$ 21.14万 - 项目类别:
Phase 2 of Growth Hormone for Treatment of Albright Hereditary Osteodystrophy
生长激素治疗奥尔布赖特遗传性骨营养不良症的第二阶段
- 批准号:
8143273 - 财政年份:2010
- 资助金额:
$ 21.14万 - 项目类别:
Phase 2 of Growth Hormone for Treatment of Albright Hereditary Osteodystrophy
生长激素治疗奥尔布赖特遗传性骨营养不良症的第二阶段
- 批准号:
8320750 - 财政年份:2010
- 资助金额:
$ 21.14万 - 项目类别:
Phase 2 of Growth Hormone for Treatment of Albright Hereditary Osteodystrophy
生长激素治疗奥尔布赖特遗传性骨营养不良症的第二阶段
- 批准号:
8032580 - 财政年份:2010
- 资助金额:
$ 21.14万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非洲栽培稻抗稻瘟病基因Pi69(t)的功能等位基因克隆及进化解析
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
相似海外基金
Sex, Physiological State, and Genetic Background Dependent Molecular Characterization of CircuitsGoverning Parental Behavior
控制父母行为的回路的性别、生理状态和遗传背景依赖性分子特征
- 批准号:
10661884 - 财政年份:2023
- 资助金额:
$ 21.14万 - 项目类别:
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention
运动坚持和认知能力下降:与黑人社区合作制定和测试目标设定和运动强度干预措施
- 批准号:
10767102 - 财政年份:2023
- 资助金额:
$ 21.14万 - 项目类别:
Role of apoE-mediated meningeal lymphatic remodeling in the pathophysiology of Alzheimer’s disease
apoE 介导的脑膜淋巴重塑在阿尔茨海默病病理生理学中的作用
- 批准号:
10734287 - 财政年份:2023
- 资助金额:
$ 21.14万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 21.14万 - 项目类别:
Association of genetic variation near the dopamine D2 receptor gene and other polymorphisms that modulate dopaminergic and opioid signaling on the weight loss response to naltrexone/bupropion
多巴胺 D2 受体基因附近的遗传变异与调节多巴胺能和阿片类信号传导对纳曲酮/安非他酮减肥反应的其他多态性的关联
- 批准号:
10586181 - 财政年份:2023
- 资助金额:
$ 21.14万 - 项目类别: